Guizhou Bailing Group Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Guizhou Bailing Group Pharmaceutical has a total shareholder equity of CN¥3.5B and total debt of CN¥1.8B, which brings its debt-to-equity ratio to 51.4%. Its total assets and total liabilities are CN¥7.2B and CN¥3.7B respectively.
Key information
51.4%
Debt to equity ratio
CN¥1.80b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥170.62m |
| Equity | CN¥3.49b |
| Total liabilities | CN¥3.66b |
| Total assets | CN¥7.15b |
Recent financial health updates
Recent updates
There's No Escaping Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Muted Revenues Despite A 26% Share Price Rise
Nov 13
Does Guizhou Bailing Group Pharmaceutical (SZSE:002424) Have A Healthy Balance Sheet?
Oct 24Why Investors Shouldn't Be Surprised By Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Low P/S
Aug 15Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny
May 10Financial Position Analysis
Short Term Liabilities: 002424's short term assets (CN¥3.9B) exceed its short term liabilities (CN¥3.4B).
Long Term Liabilities: 002424's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥266.7M).
Debt to Equity History and Analysis
Debt Level: 002424's net debt to equity ratio (46.6%) is considered high.
Reducing Debt: 002424's debt to equity ratio has reduced from 54.7% to 51.4% over the past 5 years.
Debt Coverage: 002424's debt is not well covered by operating cash flow (8.8%).
Interest Coverage: Insufficient data to determine if 002424's interest payments on its debt are well covered by EBIT.